Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

NCT00557518 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been terminated early due to financial constraints.

Conditions

Diabetes Mellitus, Type 1
Diabetic Nephropathy

Interventions

DRUG: Alagebrium
DRUG: Placebo

Sponsor

Synvista Therapeutics, Inc

Collaborators

[object Object]